Skip to main content

Originally published March 25, 2014 at 4:21 PM | Page modified March 26, 2014 at 7:01 AM

  • Share:
  • Comments (0)
  • Print

BioLife moving up to Nasdaq’s small-cap market

By Seattle Times staff

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >


BioLife Solutions of Bothell, whose products preserve stored cells, tissues and organs for life-science applications, said it will start trading Wednesday on the Nasdaq Capital Market, NASDAQ’s market for small-cap companies.

The company, previously traded over the counter, said in a regulatory filing it has completed the sale of $15.4 million in stock and warrants and erased $14.3 million in debt by converting it to equity on similar terms.

BioLife last month reported 2013 sales of $8.5 million, up 58 percent from the prior year, and a net loss of $1.1 million, down from $1.7 million.

The company said it will retain its current ticker symbol, BLFS. The securities sale and debt-to-equity conversion increased BioLife’s outstanding shares to 12 million, according to president and CEO Mike Rice, yielding a market capitalization of nearly $50 million at Tuesday’s closing price of $3.85.

Four weeks for 99 cents of unlimited digital access to The Seattle Times. Try it now!

News where, when and how you want it

Email Icon

Relive the magic

Relive the magic

Shop for unique souvenirs highlighting great sports moments in Seattle history.



The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited content access is included with most subscriptions.

Subscriber login ►